Atypical femoral fractures: a complication of prolonged bisphosphonate therapy?

Michael P Falkenberg
Med J Aust 2011; 194 (2): . || doi: 10.5694/j.1326-5377.2011.tb04181.x
Published online: 17 January 2011

To the Editor: Girgis and Seibel1 are to be congratulated as endocrinologists for raising the important issue of bisphosphonate therapy and femoral fractures. This is a relatively new phenomenon that even a couple of years ago, although already documented, did not seem to be on many endocrinologists’ radar.

  • Michael P Falkenberg

  • Northeast Health Wangaratta, Wangaratta, VIC.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.